Kids Disease Child Disease Encyclopedia
Illustration representing Acute Post-Streptococcal Glomerulonephritis (APSGN)
Severe Glomerular Boundary Filtration Pathology

Acute Post-Streptococcal Glomerulonephritis (APSGN)

Post-Streptococcal Immune Complex Glomerulopathy

Primary risk age: 5 to 12 Years (Rare under 3 years)

Urgency
Severe
Typical age
5 to 12 Years (Rare under 3 years)
Body system
Renal & Urological

Typical course: Oliguria and edema resolve within 1 to 2 weeks; hematuria may take several weeks, and microscopic hematuria can persist for up to a year.

Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13

1. Summary & Pathophysiology

Post-Streptococcal Immune Complex Glomerulopathy

Pathophysiology (Development Path)

Streptococcal antigens bind to glomerular structures, prompting the formation of antigen-antibody immune complexes. These complexes deposit in the subepithelial space of the glomerular basement membrane, activating the complement cascade. This recruits neutrophils, causing glomerular inflammation, a drop in glomerular filtration rate (GFR), and fluid retention.

Primary Causes & Etiology

An immune-mediated reaction following pharyngeal or skin infection (impetigo) with nephritogenic strains of Group A Beta-Hemolytic Streptococcus.

2. Symptom Continuum

  1. Early Onset Signs

    A history of a sore throat 1 to 2 weeks prior, or skin sores 3 to 6 weeks prior, followed by the appearance of mild periorbital edema.

  2. Progressive Phase

    Gross hematuria: urine appears tea-colored, smoky, or cola-colored. Mild to moderate oliguria (reduced urine output) and mild hypertension.

  3. Severe Indicators

    Severe volume overload leading to acute hypertensive encephalopathy (marked by headache, seizures, or confusion) and pulmonary edema.

3. Clinical Verification

Urinalysis showing dysmorphic red blood cells, RBC casts, and mild-to-moderate proteinuria. Serum complement level C3 is characteristically low. Elevated anti-streptolysin O (ASO) titer.

4. Care & Elements Plan

Primary Care Treatment Plan

Supportive management focusing on fluid restriction, sodium-restricted diet, and management of hypertension. Eradicate any remaining streptococcal infection with antibiotics.

Home Support Elements

Monitor and restrict daily fluid intake as advised. Weigh the child daily to monitor fluid retention. Avoid adding sodium to meals.

Generic Active Ingredients (No Brands)

  • Furosemide (generic loop diuretic active ingredient to manage volume overload and hypertension)
  • Nifedipine or Hydralazine (generic active anti-hypertensive agents for severe blood pressure spikes)
  • Penicillin V (to eradicate remaining GAS bacteria).

Lists active elements only. Never administer self-designed therapies.

5. Doctor Critical Lines

Critical Thresholds: When to See a Doctor

Seek prompt care if a child develops tea-colored urine, facial puffiness, a significant decrease in urine output, or a severe headache weeks after a sore throat or skin infection.

6. Vaccine & Prevention

Routine Prophylaxis (Prevention)

Prompt and complete antibiotic treatment of all Group A Streptococcal infections.

Immunization Context

No vaccine is available targeting Group A Streptococcus.

7. Timelines & Outlook

Active Timeline

Oliguria and edema resolve within 1 to 2 weeks; hematuria may take several weeks, and microscopic hematuria can persist for up to a year.

Expected Prognosis

Excellent. Over 95% of children achieve complete recovery with normal renal function restored. Long-term renal damage is extremely rare in pediatric patients.

Potential Untreated Complications

Acute renal failure, hypertensive crisis, hypertensive encephalopathy, and congestive heart failure.